LifeVantage Corp (NASDAQ:LFVN) reached a new 52-week high during trading on Wednesday . The company traded as high as $14.95 and last traded at $14.65, with a volume of 283122 shares. The stock had previously closed at $14.40.
The company has a quick ratio of 1.16, a current ratio of 1.72 and a debt-to-equity ratio of 0.12. The firm has a market capitalization of $189.25 million, a P/E ratio of 28.73 and a beta of 0.97.
LifeVantage (NASDAQ:LFVN) last released its earnings results on Thursday, November 1st. The company reported $0.07 EPS for the quarter. LifeVantage had a return on equity of 35.56% and a net margin of 2.79%. The firm had revenue of $55.61 million during the quarter. As a group, research analysts predict that LifeVantage Corp will post 0.56 earnings per share for the current fiscal year.
Several institutional investors have recently added to or reduced their stakes in the stock. Manatuck Hill Partners LLC purchased a new position in LifeVantage during the second quarter valued at approximately $475,000. Renaissance Technologies LLC raised its position in LifeVantage by 23.4% during the second quarter. Renaissance Technologies LLC now owns 743,451 shares of the company’s stock valued at $4,736,000 after acquiring an additional 140,823 shares in the last quarter. Dimensional Fund Advisors LP raised its position in LifeVantage by 14.1% during the second quarter. Dimensional Fund Advisors LP now owns 146,288 shares of the company’s stock valued at $932,000 after acquiring an additional 18,116 shares in the last quarter. Millennium Management LLC raised its position in LifeVantage by 8.9% during the second quarter. Millennium Management LLC now owns 107,069 shares of the company’s stock valued at $682,000 after acquiring an additional 8,764 shares in the last quarter. Finally, BlackRock Inc. raised its position in LifeVantage by 7.7% during the second quarter. BlackRock Inc. now owns 76,605 shares of the company’s stock valued at $488,000 after acquiring an additional 5,475 shares in the last quarter. 29.03% of the stock is owned by hedge funds and other institutional investors.
TRADEMARK VIOLATION WARNING: “LifeVantage (LFVN) Hits New 1-Year High at $14.95” was first published by Baseball Daily News and is the sole property of of Baseball Daily News. If you are viewing this article on another website, it was illegally copied and reposted in violation of US & international copyright and trademark law. The original version of this article can be accessed at https://www.baseballdailydigest.com/news/2018/12/06/lifevantage-lfvn-hits-new-1-year-high-at-14-95.html.
LifeVantage Company Profile (NASDAQ:LFVN)
LifeVantage Corporation engages in the identification, research, development, and distribution of nutraceutical dietary supplements and skin care products. The company offers Protandim, a scientifically-validated dietary supplement; LifeVantage TrueScience, an anti-aging skin care product; Axio, a line of energy drink mixes; Omega+, a fish oil dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and Vitamin D3; and PhysIQ, a weight management system, as well as Petandim for Dogs, a companion pet supplement formulated to treat oxidative stress in dogs.
Recommended Story: Intrinsic Value and Stock Selection
Receive News & Ratings for LifeVantage Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifeVantage and related companies with MarketBeat.com's FREE daily email newsletter.